Safety and Immunogenicity of Ervebo ® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination With the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC
Conditions: Ebola Virus Disease Interventions: Drug: Zabdeno ® booster; Drug: Ervebo® booster Sponsors: Institute of Tropical Medicine, Belgium; Institut National pour la Recherche Biomedicale (INRB) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials

Immunology of Ebola Vaccine
Conditions: Ebola Virus Disease Interventions: Biological: Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV ∆G-ZEBOV-GP) Sponsors: Emory University; Washington University School of Medicine; Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials

Addressing Medium- to Long-term EBOLA Associated Psychological Distress and Psychosocial Problems in Central Uganda
Conditions: Ebola Virus Disease Interventions: Behavioral: Ebola+D intervention Sponsors: MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials

RedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo Study
TEL AVIV, Israel and RALEIGH, NC, Oct. 3, 2023. RedHill Biopharma Ltd. ( " RedHill " or the " Company " ), a specialty biopharmaceutical company, today announced that novel, twice daily, oral opaganib[1], delivered a statistically significant increase in... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 3, 2023 Category: Pharmaceuticals Source Type: clinical trials

REVIVE (Response to the Ebola Virus Vaccine)
Condition:   Ebola Virus Disease Intervention:   Biological: rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO) Sponsors:   Tulane University;   Kenema Government Hospital;   Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Solidarity/Tokomeza Ebola Trial
Condition:   Sudan Ebola Virus Vaccines Interventions:   Biological: CAd3;   Biological: ChAdox1;   Biological: rVSV-SUDV;   Other: Control Sponsors:   Makerere University;   Makerere University Lung Institute;   MRC/UVRI and LSHTM Uganda Research Unit;   Makerere University Walter Reed Program;   Epicentre;   Uganda Virus Research Institute-International Aids Vaccine Initiative;   Ministry of Health, Uganda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2023 Category: Research Source Type: clinical trials